Cleo Diagnostics is bringing to market a simple blood test for the accurate and early diagnosis of ovarian cancer.
Cleo Diagnostics has raised $3.3M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2025.
Cleo Diagnostics is headquartered in Melbourne, Australia.
Cleo Diagnostics is bringing to market a simple blood test for the accurate and early diagnosis of ovarian cancer.
Cleo Diagnostics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cleo Diagnostics — Funding & Investors." VCBacked, December 18, 2025, https://www.vcbacked.co/company/cleo-diagnostics. Accessed August 15, 2026.
VCBacked. (2025). Cleo Diagnostics — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/cleo-diagnostics
{{cite web |title=Cleo Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/cleo-diagnostics |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated